Chatterjee Abhishek, Grover Surbhi, Gurram Lavanya, Sastri Supriya, Mahantshetty Umesh
Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI) Mumbai, India.
Department of Radiation Oncology, University of Pennsylvania, Pennsylvania, PA, USA.
J Contemp Brachytherapy. 2019 Dec;11(6):527-533. doi: 10.5114/jcb.2019.90448. Epub 2019 Dec 6.
Cervical cancer is the most common gynecological cancer in India. Uniform protocol-based treatment is important for achieving optimal outcomes. We undertook a survey to investigate patterns of care with special regard to patterns of care in cervical cancer brachytherapy in India.
A 17-question online survey was sent to radiation oncologists across India. Respondents were required to have a minimum of 1-year experience. One response per center was accepted and deemed as representative.
Out of 116 centers, 59 responses were generated. Two-thirds (66.1%) were from academic centers and the majority (96.6%) used high-dose-rate (HDR) brachytherapy. The centers treated an average of 255 patients per year (median 161 patients, IQR 76-355). The majority were locally advanced cancers (FIGO 2009 stage II-IV 87.5%). External beam radiotherapy (EBRT) schedules were fairly consistent, administering doses of 45-50 Gy over 5 weeks. Brachytherapy was performed towards EBRT completion by 37/59 (62%) and 43/59 (74.3%) centers used a schedule of 7 Gy × 4 fractions (HDR). Brachytherapy was commonly performed under anesthesia (spinal/general: 44% each) with ultrasound (USG) guidance (29%). Computed tomography (CT) imaging (65%) and orthogonal X-rays (35%) represented the most common imaging for planning, while point A prescription (66%) or GEC-ESTRO based parameters (35%) with manual/geometric methods represented the most common methodology for dose volume prescription and optimization. Overall treatment time (OTT) reported was within 49-56 days in 50%. Complex implants (IC + IS) were performed for more than 30% of cases by 3 centers.
Our survey suggested a fairly uniform treatment paradigm for cervical cancer brachytherapy, with a progressive shift from 2D to 3D image-based parameters for planning, with persistence of point A based prescription. Further efforts are needed to augment and ease this transition.
宫颈癌是印度最常见的妇科癌症。基于统一方案的治疗对于实现最佳治疗效果至关重要。我们开展了一项调查,以研究印度宫颈癌近距离放疗的护理模式,特别关注护理模式。
向印度各地的放射肿瘤学家发送了一份包含17个问题的在线调查问卷。受访者需至少有1年工作经验。每个中心只接受一份回复,并将其视为具有代表性。
在116个中心中,共收到59份回复。三分之二(66.1%)来自学术中心,大多数(96.6%)采用高剂量率(HDR)近距离放疗。这些中心每年平均治疗255例患者(中位数为161例患者,四分位间距为76 - 355例)。大多数为局部晚期癌症(国际妇产科联盟2009年分期II - IV期占87.5%)。外照射放疗(EBRT)方案相当一致,在5周内给予45 - 50 Gy的剂量。37/59(62%)的中心在EBRT完成时进行近距离放疗,43/59(74.3%)的中心采用7 Gy×4分次(HDR)的方案。近距离放疗通常在麻醉下进行(脊髓麻醉/全身麻醉:各占44%),并采用超声(USG)引导(29%)。计算机断层扫描(CT)成像(65%)和正交X线(35%)是最常用的计划成像方式,而A点处方(66%)或基于GEC - ESTRO的参数(35%)以及手动/几何方法是最常用的剂量体积处方和优化方法。报告的总体治疗时间(OTT)在49 - 56天内的占50%。3个中心对超过30%的病例进行了复杂植入(IC + IS)。
我们的调查表明,宫颈癌近距离放疗的治疗模式相当统一,从基于二维图像的参数规划逐渐向基于三维图像的参数规划转变,同时仍保留基于A点的处方。需要进一步努力来加强和简化这种转变。